Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -57.11% is 69% above its 4-year average of -181.67%, near the high end of its 4-year range (-4298.31%–-36.31%).
As of the fiscal period ended Tuesday, June 30, 2026. 11.95% below its 12-month average of -51.02%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -57.11%.
RETURN ON INVESTED CAPITAL (ROIC)
-57.11%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-51.02%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-140.30%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-11.95%
CURRENT VS 3Y AVG
+59.29%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.80%
median of 696 covered companies
CURRENT VS SECTOR MEDIAN
-68.97%
vs the sector median at left
Aclarion, Inc.
Market Cap
$6.66M
Return on Invested Capital (ROIC)
-57.11%
TTM Avg
-51.02%
3Y Avg
-140.30%
5Y Avg
N/A
Market Cap
$6.50M
Return on Invested Capital (ROIC)
-107.99%
TTM Avg
-407.39%
3Y Avg
-445.97%
5Y Avg
-342.27%
Market Cap
$6.75M
Return on Invested Capital (ROIC)
-219.15%
TTM Avg
-109.13%
3Y Avg
-72.14%
5Y Avg
-33.59%
Market Cap
$6.43M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-251.59%
3Y Avg
-2172.61%
5Y Avg
-1769.42%
Market Cap
$6.98M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-383.35%
3Y Avg
-220.46%
5Y Avg
-246.83%
Market Cap
$6.99M
Return on Invested Capital (ROIC)
-90.17%
TTM Avg
-79.44%
3Y Avg
-64.42%
5Y Avg
-71.54%
Market Cap
$6.32M
Return on Invested Capital (ROIC)
-117.93%
TTM Avg
-116.75%
3Y Avg
-95.39%
5Y Avg
-83.55%
Market Cap
$6.31M
Return on Invested Capital (ROIC)
-209.05%
TTM Avg
-147.42%
3Y Avg
-107.09%
5Y Avg
-98.13%
Market Cap
$6.98M
Return on Invested Capital (ROIC)
-102.91%
TTM Avg
-91.30%
3Y Avg
-374.81%
5Y Avg
-315.39%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aclarion, Inc. (ACON) | $6.66M | -57.11% | -51.02% | -140.30% | N/A |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.50M | -107.99% | -407.39% | -445.97% | -342.27% |
| Co-Diagnostics, Inc. (CODX)vs › | $6.75M | -219.15% | -109.13% | -72.14% | -33.59% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.43M | N/A | -251.59% | -2172.61% | -1769.42% |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $6.98M | N/A | -383.35% | -220.46% | -246.83% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.99M | -90.17% | -79.44% | -64.42% | -71.54% |
| Biomerica, Inc. (BMRA)vs › | $6.32M | -117.93% | -116.75% | -95.39% | -83.55% |
| Femasys Inc. (FEMY)vs › | $6.31M | -209.05% | -147.42% | -107.09% | -98.13% |
| Mangoceuticals, Inc. (MGRX)vs › | $6.98M | -102.91% | -91.30% | -374.81% | -315.39% |
| Longeveron Inc. (LGVN)vs › | $7.27M | -211.58% | -206.45% | -187.44% | -143.49% |
ROIC
-57.1%
ROE
-54.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -57.11% |
| 2026-03-31 | -43.49% |
| 2025-12-31 | -54.95% |
| 2025-09-30 | -54.92% |
| 2025-06-30 | -44.61% |
| 2025-03-31 | -36.31% |
| 2024-12-31 | -568.32% |
| 2024-09-30 | -192.57% |
| 2024-06-30 | -194.25% |
| 2024-03-31 | -156.51% |
| 2023-12-31 | -1225.96% |
| 2023-06-30 | -4298.31% |
| 2023-03-31 | -564.79% |
| 2022-12-31 | -267.11% |
| 2022-09-30 | -193.94% |
| 2022-06-30 | -114.44% |
